Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase EARLY_PHASE1 4Phase 1 4Phase NA 3Phase 3 3

Status

Terminated 2Recruiting 2

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Endocrine 2CNS 2

Conditions

Glioma 2Recurrence 1Pheochromocytoma 1Insulinoma 1Hypoglycemia 1Hyperinsulinism 1Glioblastoma 1Endocrine System Diseases 1Congenital Hyperinsulinism 1

Interventions

Cyclophosphamide 626pembrolizumab 505Paclitaxel 456Gemcitabine 439Carboplatin 437Cisplatin 420Radiotherapy 382fludarabine 367Nivolumab 340Docetaxel 278Bevacizumab 276Irinotecan 258Magnetic Resonance Spectroscopy 245Fluorouracil 229Dexamethasone 225Specimen Handling 223Capecitabine 218Rituximab 206Oxaliplatin 201Cytarabine 201Ipilimumab 198Temozolomide 197Biopsy 197fludarabine phosphate 194Etoposide 181Lenalidomide 176Doxorubicin 175Leucovorin 174Cetuximab 171Injections 170

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Interventional × fluorodopa F 18 × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

NCT02021604 2024-07-16

Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma

Cook Children's Health Care System

Phase 1 Recruiting
250 enrolled
Endocrine

Hyperinsulinism, Hypoglycemia, Insulinoma, Congenital Hyperinsulinism

NCT02176720 2018-08-17

Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma

The Methodist Hospital Research Institute

Phase 1 Terminated
31 enrolled
CNS

Glioblastoma, Glioma, Recurrence

NCT02371031 2016-11-30

FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas

Washington University School of Medicine

Phase 1 Terminated
11 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡